Ambalal Sarabhai Enterprises Ltd

NSE: AMBASARABH BSE: 500009

₹33.17

(4.60%)

Sun, 17 May 2026, 07:55 pm

MTF 5xInvest in Ambalal Sarabhai Enterprises Ltd with 5x Leverage Buy with MTF

Market Cap2.54B

PE Ratio23.04

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Ambalal Sarabhai Enterprises News

Ambalal Sarabhai Board Meet Set for May 21, 2026

Ambalal Sarabhai Enterprises schedules Board Meeting on May 21, 2026 to approve audited financial results for Q4 and FY26, and fix AGM date.

14 May 2026

companies

Ambalal Sarabhai Submits SEBI Compliance Certificate

Ambalal Sarabhai Enterprises Limited filed mandatory certificate under SEBI Regulation 74(5) for period ended March 31, 2026, confirming proper dematerialization processes.

09 Apr 2026

companies

Ambalal Sarabhai Enterprises Reports Mixed Q2 Performance with Consolidated Loss Despite Revenue Growth

Ambalal Sarabhai Enterprises Limited reported consolidated revenue from operations of Rs 4,444.92 lakhs for the quarter ended September 30, 2025, compared to Rs 4,470.61 lakhs in the same period last year. The company posted a consolidated net loss of Rs 36.03 lakhs for the quarter versus a profit of Rs 261.99 lakhs in the previous year. For the half-year period, consolidated revenue reached Rs 8,478.80 lakhs with net profit of Rs 766.32 lakhs. On a standalone basis, the company recorded a loss of Rs 38.24 lakhs for the quarter. The company operates in two business segments - Pharmaceuticals and Electronics. Basic earnings per share stood at negative Rs 0.07 for the quarter. The Board of Directors approved these unaudited financial results in their meeting held on November 12, 2025.

12 Nov 2025

earnings

Ambalal Sarabhai Enterprises' Joint Venture CoSara Diagnostics Explores SPAC Transaction

Ambalal Sarabhai Enterprises Limited announced that Co-Diagnostics Inc., its joint venture partner in CoSara Diagnostics Pvt. Ltd., has engaged Maxim Group LLC as exclusive financial advisor to explore strategic alternatives for the Indian joint venture. The options include a potential merger with a Special Purpose Acquisition Company (SPAC) or similar entity listed on a U.S. national securities exchange. CoSara Diagnostics, established in 2017, is a joint venture between Co-Diagnostics Inc. and Synbiotics Ltd., with the latter being a group company of Asence Inc., both subsidiaries of Ambalal Sarabhai Enterprises. The joint venture focuses on manufacturing and selling molecular diagnostics products to patients and healthcare providers in international markets, with initial focus on India. Co-Diagnostics CEO Dwight Egan stated the company aims to unlock value for CoSara and shareholders while helping the venture realize its founding vision.

06 Nov 2025

order&deals

Ambalal Sarabhai's Telerad Division Wins Best Regional Distributor Award at Broadcast India Show 2025

Ambalal Sarabhai Enterprises Limited announced that its Telerad division, which operates under Systronics India Limited, received the 'Best Regional Distributor — Broadcast - West Award' at the Broadcast India Show 2025 held in Mumbai in October 2025. Telerad is described as a total solution company and leading system integrator that provides complete end-to-end solutions in broadcast segments. The award recognizes Telerad's leadership in delivering innovative broadcast solutions and exceptional services to industries.

27 Oct 2025

stock

Showing 1–5 of 7

Rows per page:

Market Current News

Dow Jones Unofficially Closes Down 517.28 Points

Dow Jones unofficially closes down 517.28 points, or 1.03%, at 49,546.18, reversing the prior provisional gain of 356.50 points, or 0.72%, at 50,049.70.

15 May 2026

global

Nasdaq Unofficially Closes Down 402.48 Points, or 1.51%

Nasdaq unofficially closed down 402.48 points, or 1.51%, at 26,232.75, extending the session's earlier post-open decline of 376.95 points, or 1.42%, to 26,258.27.

15 May 2026

global

Brent Crude Futures Rise 3.35% to $109.26/bbl

Brent crude futures closed at $109.26/bbl, rising $3.54 or 3.35% in the latest session, marking a strong rebound after the prior session's marginal gain of 0.09%.

15 May 2026

commodities

US Crude Oil Futures Settle at USD 105.42/Bbl

US crude oil futures settled at USD 105.42 per barrel, gaining USD 4.25 or 4.20%, reflecting a notable upward move in oil prices.

15 May 2026

commodities

Bagmane Prime Office REIT Files Pre-Listing Unitholding Pattern

Bagmane Prime Office REIT submits unitholding pattern one day prior to listing on May 15, 2026, with sponsor group holding 82.81% and public holding at 17.19% of 3,40,00,00,000 total units.

15 May 2026

ipo

Showing 1–5 of 93685

Rows per page:

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800